US 10517889
Modulators of SMAD7 expression
granted A61KA61K31/7042A61K31/7125
Quick answer
US patent 10517889 (Modulators of SMAD7 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/7042, A61K31/7125, A61P, A61P1/00